Newly Diagnosed Multiple Myeloma is Associated with Hypercoagulablity and High Risk of VTE. The Roadmap Study

被引：0

作者：

Fotiou, Despina ^{[1
]}

Gerotziafas, Grigorios ^{[2
]}

Zagouri, Flora ^{[3
]}

Sergentanis, Theodoros ^{[3
]}

机构：

[1] Alexandra Hosp, Oncol & Hematol Dept, Athens, Greece

[2] Tenon Univ Hosp, Fac Med Pierre Marie Curie, Serv Hematol Biol, Paris, France

[3] Natl & Kapodistrian Univ Athens, Dept Clin Therapeut, Athens, Greece

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2017年 / 17卷 / 01期

关键词：

D O I：

10.1016/j.clml.2017.03.174

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PS-172

引用

页码：E97 / E97

页数：1

共 50 条

[31] Substratification of Patients with Newly Diagnosed Standard-Risk Multiple Myeloma
Binder, Moritz
Rajkumar, S. Vincent
Ketterling, Rhett P.
Dispenzieri, Angela
Lacy, Martha Q.
Gertz, Morie A.
Buadi, Francis K.
Hayman, Suzanne R.
Hwa, Yi L.
Zeldenrust, Steven R.
Lust, John A.
Russell, Stephen J.
Leung, Nelson
Kapoor, Prashant
Go, Ronald S.
Gonsalves, Wilson I.
Kyle, Robert A.
Kumar, Shaji K.
BLOOD, 2017, 130
[32] Development of an Inclusive Risk Prognostic Index for Newly Diagnosed Multiple Myeloma
Derman, Ben A.
Belli, Andrew J.
Wang, Ching-Kun
Hansen, Eric
Langerman, Spencer S.
Jakubowiak, Andrzej
Chiu, Brian C-H
BLOOD, 2021, 138 : 3789 - +
[33] Risk and Incidence of Venous Thromboembolism in Newly Diagnosed Multiple Myeloma Patients
Nabar, Leeladhar
Khan, Hamza
Nair, Aditya
Mishra, Dhyey
Shah, Jash
Lalwani, Devansh
Talati, Shriraj
Tembhare, Prashant
Nayak, Lingaraj
Shetty, Alok
Rajpal, Sweta
Chatterjee, Gaurav
Khan, Ajmat
Mirgh, Sumeet
Jindal, Nishant
Gokarn, Anant
Punatar, Sachin
Jain, Hasmukh
Patkar, Nikhil
Shetty, Dhanlaxmi
Subramanian, Papagudi
Gujral, Sumeet
Bagal, Bhausaheb
Sengar, Manju
Khattry, Navin
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S121 - S121
[34] Underweight as a risk factor of mortality in patients with newly diagnosed multiple myeloma
Tsai, Chun-Kuang
Yeh, Chiu-Mei
Hsu, Te-Lin
Li, Chia-Ju
Tin, Chian
Hsiao, Liang-Tsai
Liu, Yao-Chung
Wang, Hao-Yuan
Ko, Po-Shen
Chen, Po-Min
Liu, Jin-Hwang
Gau, Jyh-Pyng
Liu, Chia-Jen
SUPPORTIVE CARE IN CANCER, 2021, 29 (07) : 3991 - 3999
[35] Development of a Clinical Risk Stratification for Patients with Newly Diagnosed Multiple Myeloma
Mao, Xuehan
Xu, Yan
Yan, Yuting
Liu, Jiahui
Fan, Huishou
Sui, Weiwei
Deng, Shuhui
Li, Zengjun
Qiu, Lugui
An, Gang
BLOOD, 2019, 134
[36] Determination of the individual infection risk for newly diagnosed patients with multiple myeloma
Kaebisch, E.
Heck, C.
Frentsch, M.
Blau, I. -W
Nogai, A.
Bullinger, L.
Na, I. -K
ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 48 - 48
[37] Impede VTE vs saved scores to predict the risk of venous thromboembolism in newly diagnosed multiple myeloma with immunomodulatory drugs: how to choose?
Teste, A.
Thollot, H.
Tinquaut, F.
Sotton, S.
Tardy, B.
Moreau, P.
Fermand, J. P.
Hulin, C.
Elalamy, I.
Leleu, X.
Guyotat, D.
Chalayer, E.
THROMBOSIS RESEARCH, 2021, 200 : S61 - S62
[38] Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma
W I Gonsalves
S V Rajkumar
V Gupta
W G Morice
M M Timm
P P Singh
A Dispenzieri
F K Buadi
M Q Lacy
P Kapoor
M A Gertz
S K Kumar
Leukemia, 2014, 28 : 2060 - 2065
[39] Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma
Gonsalves, W. I.
Rajkumar, S. V.
Gupta, V.
Morice, W. G.
Timm, M. M.
Singh, P. P.
Dispenzieri, A.
Buadi, F. K.
Lacy, M. Q.
Kapoor, P.
Gertz, M. A.
Kumar, S. K.
LEUKEMIA, 2014, 28 (10) : 2060 - 2065
[40] High SOX2 expression is associated with poor survival in patients with newly diagnosed multiple myeloma
Xinhe Shan
Qi Long
Alfred L. Garfall
Sandra P. Susanibar-Adaniya
Blood Cancer Journal, 13

← 1 2 3 4 5 →